ReviewAmerican journal of physiology. Cell physiology2025
Emerging roles of astrocytes in autonomic control of blood pressure and hypertension.
Review in American journal of physiology. Cell physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Central Sympathetic Nerve Activation-Mediated Hypertension: Target Mechanisms and Multimodal Interventions-From Basic Research to Clinical Translation.International journal of molecular sciences · 2026Review
- Neurovascular unit remodeling: focusing on glial cells in stroke injury and recovery.Frontiers in cellular neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Astrocytes, traditionally viewed as passive support cells, have emerged as critical regulators of neuronal signaling, autonomic function, and cardiovascular homeostasis. Accumulating evidence highlights the active participation of astrocytes in maintaining neurotransmitter balance, ion homeostasis, synaptic plasticity, and cerebral metabolism. In particular, astrocytes form integral components of tripartite synapses, mediating neuronal communication through calcium-dependent release of gliotransmitters, including ATP, glutamate, d-serine, and γ-aminobutyric acid. This astrocyte-mediated signaling is essential in modulating autonomic circuits involved in blood pressure regulation and sympathetic nerve activity. Recent research underscores the role of astrocyte dysfunction-mediated inflammation, termed astrogliosis, in driving pathological states such as hypertension. Astrocyte activation within critical cardiovascular control centers, including the nucleus tractus solitarii, paraventricular nucleus, and rostral ventrolateral medulla, promotes neuroinflammation, disrupts neurotransmitter clearance, and enhances sympathetic nervous system activity. These processes contribute significantly to hypertension development, particularly under conditions of metabolic stress, such as obesity and high-fat diet consumption. Key molecular mechanisms implicated include NF-κB-mediated inflammatory pathways, impaired astrocytic glutamate transporters, overactivation of angiotensin II signaling, and abnormal gliotransmitter release. In this review, we summarize recent advances in our understanding of the physiological roles of astrocytes in autonomic and cardiovascular regulation and discuss the pathological consequences of astrocyte-driven neuroinflammation in hypertension. We further outline promising directions for future research and therapeutic interventions targeting astrocytic pathways, offering potential new strategies for preventing or reversing autonomic dysfunction and hypertension.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.